CLOV vs SNDL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CLOV

45.8
AI Score
VS
CLOV Wins

SNDL

35.6
AI Score

Investment Advisor Scores

CLOV

46score
Recommendation
HOLD

SNDL

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV SNDL Winner
Forward P/E 37.7358 91.7431 CLOV
PEG Ratio 0 0 Tie
Revenue Growth 53.1% -2.5% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.8/100 35.6/100 CLOV
Profit Margin 0.4% -6.4% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: +3.3% · 3M: +10.7% SNDL 1M: +22.4% · 3M: +13.6%

Current Technical Phase

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 60

RSI (14): 59.7 · Price: $4.97

SNDL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 63

RSI (14): 63.5 · Price: $1.42

Fundamentals Snapshot

Metric CLOV SNDL
Market Cap — —
Forward P/E 27.6 -94.7
Trailing P/E 493.0 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.2% 0.3%
Operating Margin 0.0% 0.0%
EPS 0.01 -0.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.